1. Introduction Orphan drugs and rare diseases are at the forefront of modern pharmaceutical innovation, providing hope for patients with previously untreatable or overlooked conditions. Türkiye, with its strategic healthcare reforms and a growing commitment to personalized medicine, has taken steps to develop a legal and regulatory environment supporting the development, registration, and access to […]